Disc Medicine to host webcast Monday to discuss topline results from APOLLO Phase 3 trial of bitopertin

Disc Medicine will host a corporate webcast on Monday, October 19 at 8 AM ET to discuss topline results from the APOLLO Phase 3 trial of bitopertin in erythropoietic protoporphyria (EPP).

Detected & updated continuously · Source: Nebula